Microbiology and Immunology

You are here

Home > Publications > Publications

Publications

Found 192 results
Author Title Type [ Year(Desc)]
Filters: First Letter Of Last Name is F  [Clear All Filters]
1994
Prescott J, Falck-Pedersen E.  1994.  Sequence elements upstream of the 3' cleavage site confer substrate strength to the adenovirus L1 and L3 polyadenylation sites.. Mol Cell Biol. 14(7):4682-93.
Rubin BP, Ferguson DO, Holloman WK.  1994.  Structure of REC2, a recombinational repair gene of Ustilago maydis, and its function in homologous recombination between plasmid and chromosomal sequences.. Mol Cell Biol. 14(9):6287-96.
Gershengorn MC, Heinflink M, Nussenzveig DR, Hinkle PM, Falck-Pedersen E.  1994.  Thyrotropin-releasing hormone (TRH) receptor number determines the size of the TRH-responsive phosphoinositide pool. Demonstration using controlled expression of TRH receptors by adenovirus mediated gene transfer.. J Biol Chem. 269(9):6779-83.
1995
MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie QW, Sokol K, Hutchinson N.  1995.  Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase.. Cell. 81(4):641-50.
Onel K, Thelen MP, Ferguson DO, Bennett RL, Holloman WK.  1995.  Mutation avoidance and DNA repair proficiency in Ustilago maydis are differentially lost with progressive truncation of the REC1 gene product.. Mol Cell Biol. 15(10):5329-38.
Geissdörfer W, Frosch SC, Haspel G, Ehrt S, Hillen W.  1995.  Two genes encoding proteins with similarities to rubredoxin and rubredoxin reductase are required for conversion of dodecane to lauric acid in Acinetobacter calcoaceticus ADP1.. Microbiology (Reading). 141 ( Pt 6):1425-32.
1996
Gall J, Kass-Eisler A, Leinwand L, Falck-Pedersen E.  1996.  Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes.. J Virol. 70(4):2116-23.
Yoon SO, Lois C, Alvirez M, Alvarez-Buylla A, Falck-Pedersen E, Chao MV.  1996.  Adenovirus-mediated gene delivery into neuronal precursors of the adult mouse brain.. Proc Natl Acad Sci U S A. 93(21):11974-9.
Kass-Eisler A, Leinwand L, Gall J, Bloom B, Falck-Pedersen E.  1996.  Circumventing the immune response to adenovirus-mediated gene therapy.. Gene Ther. 3(2):154-62.
Chehimi J, Ma X, Chouaib S, Zyad A, Nagashunmugam T, Wojcik L, Chehimi S, Nissim L, Frank I.  1996.  Differential production of interleukin 10 during human immunodeficiency virus infection.. AIDS Res Hum Retroviruses. 12(12):1141-9.
Wolff G, Mastrangeli A, Heinflink M, Falck-Pedersen E, Gershengorn MC, Crystal RG.  1996.  Ectopic expression of thyrotropin releasing hormone (TRH) receptors in liver modulates organ function to regulate blood glucose by TRH.. Nat Genet. 12(3):274-9.
Yeaman C, Heinflink M, Falck-Pedersen E, Rodriguez-Boulan E, Gershengorn MC.  1996.  Polarity of TRH receptors in transfected MDCK cells is independent of endocytosis signals and G protein coupling.. Am J Physiol. 270(3 Pt 1):C753-62.
Ferguson DO, Holloman WK.  1996.  Recombinational repair of gaps in DNA is asymmetric in Ustilago maydis and can be explained by a migrating D-loop model.. Proc Natl Acad Sci U S A. 93(11):5419-24.
Mastrangeli A, Harvey BG, Yao J, Wolff G, Kovesdi I, Crystal RG, Falck-Pedersen E.  1996.  "Sero-switch" adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype.. Hum Gene Ther. 7(1):79-87.
1997
Mack CA, Song WR, Carpenter H, Wickham TJ, Kovesdi I, Harvey BG, Magovern CJ, Isom OW, Rosengart T, Falck-Pedersen E et al..  1997.  Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype.. Hum Gene Ther. 8(1):99-109.
Abrahamsen K, Kong HL, Mastrangeli A, Brough D, Lizonova A, Crystal RG, Falck-Pedersen E.  1997.  Construction of an adenovirus type 7a E1A- vector.. J Virol. 71(11):8946-51.
Moller DR, Wysocka M, Greenlee BM, Ma X, Wahl L, Flockhart DA, Trinchieri G, Karp CL.  1997.  Inhibition of IL-12 production by thalidomide.. J Immunol. 159(10):5157-61.
Worgall S, Wolff G, Falck-Pedersen E, Crystal RG.  1997.  Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration.. Hum Gene Ther. 8(1):37-44.
Ferguson DO, Rice MC, Rendi MH, Kotani H, Kmiec EB, Holloman WK.  1997.  Interaction between Ustilago maydis REC2 and RAD51 genes in DNA repair and mitotic recombination.. Genetics. 145(2):243-51.
Prescott JC, Liu L, Falck-Pedersen E.  1997.  Sequence-mediated regulation of adenovirus gene expression by repression of mRNA accumulation.. Mol Cell Biol. 17(4):2207-16.
Elkon KB, Liu CC, Gall JG, Trevejo J, Marino MW, Abrahamsen KA, Song X, Zhou JL, Old LJ, Crystal RG et al..  1997.  Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors.. Proc Natl Acad Sci U S A. 94(18):9814-9.
1998
Gall JG, Crystal RG, Falck-Pedersen E.  1998.  Construction and characterization of hexon-chimeric adenoviruses: specification of adenovirus serotype.. J Virol. 72(12):10260-4.
Karp CL, Wysocka M, Ma X, Marovich M, Factor RE, Nutman T, Armant M, Wahl L, Cuomo P, Trinchieri G.  1998.  Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance.. Eur J Immunol. 28(10):3128-36.
Coughlin CM, Salhany KE, Gee MS, LaTemple DC, Kotenko S, Ma X, Gri G, Wysocka M, Kim JE, Liu L et al..  1998.  Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis.. Immunity. 9(1):25-34.
1999
Miyazawa N, Leopold PL, Hackett NR, Ferris B, Worgall S, Falck-Pedersen E, Crystal RG.  1999.  Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors.. J Virol. 73(7):6056-65.